Healthcare -
Biotechnology - NASDAQ - US
$ 1.065
-4.05 %
$ 123 M
Market Cap
-11.83
P/E
CHRS - CAPITAL EXPENDITURES
Capital Expenditures CHRS - Coherus BioSciences, Inc.
-286 K
LAST VALUE
52.90%
2 YEAR CAGR
18.37%
5 YEAR CAGR
2.62%
10 YEAR CAGR